FDA approval of Gazyva expands therapeutic options for lupus care WASHINGTON, Oct. 20, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as...
Hence then, the article about fda approves gazyva obinutuzumab for the treatment of adults with lupus nephritis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Gazyva® (obinutuzumab) for the Treatment of Adults with Lupus Nephritis )
Also on site :
- No. 20 Virginia notches first 11-win season by beating 25th-ranked Missouri in the Gator Bowl
- Natural gas line rupture stops traffic on 5 Freeway in Castaic
- SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model